Azerbaijan vs Poland: HIV/AIDS deaths averted by antiretroviral therapy
Azerbaijan
607.42 deaths
in 2024
Poland
683 deaths
in 2021
Azerbaijan rank
87th
Poland rank
84th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Azerbaijan
- Poland
How they compare
Poland currently reports 683 deaths against 607.42 deaths in Azerbaijan, a difference of 75.58 deaths.
That makes Poland's figure about 1.1 times Azerbaijan's.
Across all 32 years both countries report, Poland has been ahead every year.
Azerbaijan ranks 87th and Poland ranks 84th of 157 countries.
Poland has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Azerbaijan | Poland | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 40.1 deaths | 40.1 deaths | Poland |
| 2000s | 12.14 deaths | 326.9 deaths | 314.76 deaths | Poland |
| 2010s | 273.78 deaths | 512.7 deaths | 238.92 deaths | Poland |
| 2020s | 531.71 deaths | 662 deaths | 130.29 deaths | Poland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Azerbaijan or Poland?
- Poland, at 683 deaths against 607.42 deaths in Azerbaijan as of 2021.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Azerbaijan and Poland?
- 75.58 deaths, with Poland ahead.
- How many years of comparable data are there for Azerbaijan and Poland?
- 32 years are reported by both, from 1990 to 2021.
- How do Azerbaijan and Poland rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Azerbaijan ranks 87th and Poland ranks 84th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.